Al Bataineh MT, Künstner A, Dash NR, Alsafar HS, Ragab M, Schmelter F, Sina C, Busch H, Ibrahim SM (2023) Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis. Sci Rep 13:1–11

Article  Google Scholar 

Allin KH, Agrawal M, Iversen AT, Antonsen J, Villumsen M, Jess T (2022) The risk of type 2 diabetes in patients with inflammatory bowel disease after bowel resections: a nationwide cohort study. Gastro Hep Adv 1:777–784

Article  PubMed  PubMed Central  Google Scholar 

Amaral LMPF, Moniz T, Silva AMN, Rangel M (2023) Vanadium compounds with antidiabetic potential. Int J Mol Sci 24:115675

Article  Google Scholar 

Arora A, Behl T, Sehgal A, Singh S, Sharma N, Bhatia S, Sobarzo-Sanchez E, Bungau S (2021) Unravelling the involvement of gut microbiota in type 2 diabetes mellitus. Life Sci 273:119311

Article  CAS  PubMed  Google Scholar 

Brazil JC, Louis NA, Parkos CA (2013) The role of polymorphonuclear leukocyte trafficking in the perpetuation of inflammation during inflammatory bowel disease. Inflamm Bowel Dis 19:1556–1565

Article  PubMed  PubMed Central  Google Scholar 

Bressenot MA (2018) Which evidence for a treat to target strategy in ulcerative colitis? Best Pract Res Clin Gastroenterol 32–33:3–8

Article  Google Scholar 

Cheng L, Jin H, Qiang Y, Wu S, Yan C, Han M, Xiao T, Yan N, An H, Zhou X, Shao Q, Xia S (2016) High fat diet exacerbates dextran sulfate sodium induced colitis through disturbing mucosal dendritic cell homeostasis. Int Immunopharmacol 40:1–10

Article  CAS  PubMed  Google Scholar 

Chung AE, Vu MB, Myers K, Burris J, Kappelman MD (2018) Crohn’s and Colitis Foundation of America Partners Patient-Powered Research Network: patient perspectives on facilitators and barriers to building an impactful patient-powered research network. Med Care 56(Suppl 1):S33–S40

Article  PubMed  PubMed Central  Google Scholar 

Danese S, Banerjee R, Cummings JF, Dotan I, Kotze PG, Leong RWL, Paridaens K, Peyrin-Biroulet L, Scott G, Van Assche G, Wehkamp J, Yamamoto-Furusho JK (2018) Consensus recommendations for patient-centered therapy in mild-to-moderate ulcerative colitis: the i Support Therapy-Access to Rapid Treatment (iSTART) approach. Intest Res 16:522–528

Article  PubMed  PubMed Central  Google Scholar 

Danese S, Roda G, Peyrin-Biroulet L (2020) Evolving therapeutic goals in ulcerative colitis: towards disease clearance. Nat Rev Gastroenterol Hepatol 17:1–2

Article  PubMed  Google Scholar 

Eichele DD, Kharbanda KK (2017) Dextran sodium sulfate colitis murine model: an indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis. World J Gastroenterol 23:6016–6029

Article  CAS  PubMed  PubMed Central  Google Scholar 

Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126:131–138

Article  CAS  PubMed  Google Scholar 

Hayes JD, Dinkova-Kostova AT (2014) The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem Sci 39:199–218

Article  CAS  PubMed  Google Scholar 

He Z, Song J, Li X, Li X, Zhu H, Wu C, Xiao W, Du X, Ni J, Li N, Liu Q (2021) Bis(ethylmaltolato)oxidovanadium (IV) alleviates neuronal apoptosis through regulating peroxisome proliferator-activated receptor γ in a triple transgenic animal model of Alzheimer’s disease. J Biol Inorg Chem 26:551–568

Hirten RP, Sands BE (2021) New therapeutics for ulcerative colitis. Annu Rev Med 72:199–213

Article  CAS  PubMed  Google Scholar 

Horowitz A, Chanez-Paredes SD, Haest X, Turner JR (2023) Paracellular permeability and tight junction regulation in gut health and disease. Nat Rev Gastroenterol Hepatol 20:417–432

Article  PubMed  PubMed Central  Google Scholar 

Huang L, Zheng J, Sun G, Yang H, Sun X, Yao X, Lin A, Liu H (2022) 5-Aminosalicylic acid ameliorates dextran sulfate sodium-induced colitis in mice by modulating gut microbiota and bile acid metabolism. Cell Mol Life Sci 79:460

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jasser-Nitsche H, Bechtold-Dalla Pozza S, Binder E, Bollow E, Heidtmann B, Lee-Barkley YH, Raile K, de Sousa G, Schramm U, Holl RW (2021) Comorbidity of inflammatory bowel disease in children and adolescents with type 1 diabetes. Acta Paediatr 110:1353–1358

Article  CAS  PubMed  Google Scholar 

Joossens M, Huys G, Cnockaert M, De Preter V, Verbeke K, Rutgeerts P, Vandamme P, Vermeire S (2011) Dysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives. Gut 60:631–637

Article  PubMed  Google Scholar 

Joshi A, Akhtar A, Saroj P, Kuhad A, Sah SP (2022) Antidepressant-like effect of sodium orthovanadate in a mouse model of chronic unpredictable mild stress. Eur J Pharmacol 919:174798

Article  CAS  PubMed  Google Scholar 

Kaur G, Kushwah AS (2024) Sodium orthovanadate protects against ulcerative colitis and associated liver damage in mice: insights into modulations of Nrf2/Keap1 and NF-κB pathways. Naunyn Schmiedebergs Arch Pharmacol 398(2):1557–1574

Article  PubMed  Google Scholar 

Khalil AA, Jameson MJ (2017) Sodium orthovanadate inhibits proliferation and triggers apoptosis in oral squamous cell carcinoma in vitro. Biochem 82(2):149–155

CAS  Google Scholar 

Khor TO, Huang MT, Kwon KH, Chan JY, Reddy BS, Kong AN (2006) Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis. Cancer Res 66:11580–11584

Article  CAS  PubMed  Google Scholar 

Kim UJ, Lee BH, Lee KH (2019) Neuroprotective effects of a protein tyrosine phosphatase inhibitor against hippocampal excitotoxic injury. Brain Res 1719:133–139

Article  CAS  PubMed  Google Scholar 

Kim HG, Jeong SG, Kim JH, Cho JY (2022) Phosphatase inhibition by sodium orthovanadate displays anti-inflammatory action by suppressing AKT-IKKβ signaling in RAW264.7 cells. Toxicol Rep 9:1883–1893

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kothari V, Galdo JA, Mathews ST (2016) Hypoglycemic agents and potential anti-inflammatory activity. J Inflamm Res 9:27–38

CAS  PubMed  PubMed Central  Google Scholar 

Kusunoki Y, Ikarashi N, Hayakawa Y, Ishii M, Kon R, Ochiai W, Machida Y, Sugiyama K (2014) Hepatic early inflammation induces downregulation of hepatic cytochrome P450 expression and metabolic activity in the dextran sulfate sodium-induced murine colitis. Eur J Pharm Sci 54:17–27

Article  CAS  PubMed  Google Scholar 

Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, Hayee B, Lomer MCE, Parkes GC, Selinger C, Barrett KJ, Davies RJ, Bennett C et al (2019) British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 68:s1–s106

Article  PubMed  PubMed Central  Google Scholar 

Laurindo LF, Santos ARO, Carvalho ACA, Bechara MD, Guiguer EL, Goulart RA, Vargas Sinatora R, Araújo AC, Barbalho SM (2023) Phytochemicals and regulation of NF-kB in inflammatory bowel diseases: an overview of in vitro and in vivo effects. Metabolites Basel. https://doi.org/10.3390/metabo13010096

Article  Google Scholar 

Li W, Khor TO, Xu C, Shen G, Jeong WS, Yu S, Kong AN (2008) Activation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosis. Biochem Pharmacol 76:1485–1489

Article  CAS  PubMed  PubMed Central  Google Scholar 

Louis E, Paridaens K, Al Awadhi S, Begun J, Cheon JH, Dignass AU, Magro F, Márquez JR, Moschen AR, Narula N, Rydzewska G, Freddi MJ, Travis SPL (2022) Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis. BMJ Open Gastroenterol 9:1–10

Article  Google Scholar 

Maconi G, Furfaro F, Sciurti R, Bezzio C, Ardizzone S, de Franchis R (2014) Glucose intolerance and diabetes mellitus in ulcerative colitis: pathogenetic and therapeutic implications. World J Gastroenterol 20:3507–3515

Article  CAS  PubMed  PubMed Central